The latest price target for GlycoMimetics (NASDAQ:GLYC) was reported by TD Cowen on July 26, 2024. The analyst firm set a price target for $0.00 expecting GLYC to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

The latest analyst rating for GlycoMimetics (NASDAQ:GLYC) was provided by TD Cowen, and GlycoMimetics downgraded their hold rating.

The last upgrade for GlycoMimetics Inc happened on November 12, 2021 when Jefferies raised their price target to $4. Jefferies previously had a hold for GlycoMimetics Inc.

The last downgrade for GlycoMimetics Inc happened on July 26, 2024 when TD Cowen changed their price target from N/A to N/A for GlycoMimetics Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GlycoMimetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GlycoMimetics was filed on July 26, 2024 so you should expect the next rating to be made available sometime around July 26, 2025.

While ratings are subjective and will change, the latest GlycoMimetics (GLYC) rating was a downgraded with a price target of $0.00 to $0.00. The current price GlycoMimetics (GLYC) is trading at is $0.17, which is out of the analyst’s predicted range.